SCHEMBL23527426

SCHEMBL23527426

ClC(Cl)(Cl)c1c2ccccc2cc2cc3ccccc3cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.43
▸ HSD17B10 Q99714 4/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ CYP1B1 Q16678 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HTR2A P28223 1/20 0.38
▸ CYP1A2 P05177 5/20 0.37
▸ CYP2A6 P11509 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ ERBB2 P04626 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6462079 0.79 ALDH1A1 (0.39) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL10987801 0.75 CYP2A6 (0.46) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL1538664 0.74 TSHR (0.45) ALDH1A1HSD17B10CYP1A2CYP2A6HPGD
SCHEMBL1538535 0.72 ALDH1A1 (0.41) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL6036938 0.71 CYP2A6 (0.48) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL4853659 0.69 ALDH1A1 (0.72) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL23664 0.69 ALDH1A1 (0.72) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL29532882 0.69 ALDH1A1 (0.72) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL4848746 0.69 ALDH1A1 (0.72) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1
SCHEMBL476842 0.69 CYP2A6 (0.61) ALDH1A1HSD17B10HIF1ACYP1B1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685702-B2 Method for producing arene compounds and arene compounds produced by the same JSI SILICONE CO. (KR) 2023-06-27 — — US disclosed
US-20210188739-A1 METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME JSI SILICONE CO. (KR) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188739-A1 METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME PFAS, FRK, AGPAT2 ALDH1A1 676/4885HSD17B10 1306/4885HIF1A 2300/4885
US-11685702-B2 Method for producing arene compounds and arene compounds produced by the same PFAS, FRK, AGPAT2 ALDH1A1 676/4885HSD17B10 1306/4885HIF1A 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback